CryoPort, Inc. (CYRX): Price and Financial Metrics
GET POWR RATINGS... FREE!
CYRX POWR Grades
- CYRX scores best on the Growth dimension, with a Growth rank ahead of 43.22% of US stocks.
- CYRX's strongest trending metric is Stability; it's been moving up over the last 51 weeks.
- CYRX ranks lowest in Value; there it ranks in the 0th percentile.
CYRX Stock Summary
- CYRX's price/sales ratio is 18.38; that's higher than the P/S ratio of 89.59% of US stocks.
- CYRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 19.01% of US stocks.
- Revenue growth over the past 12 months for Cryoport Inc comes in at 344.89%, a number that bests 97.66% of the US stocks we're tracking.
- Stocks that are quantitatively similar to CYRX, based on their financial statements, market capitalization, and price volatility, are XERS, INSP, KALA, ATEC, and ECOR.
- Visit CYRX's SEC page to see the company's official filings. To visit the company's web site, go to www.cryoport.com.
CYRX Valuation Summary
- In comparison to the median Industrials stock, CYRX's price/sales ratio is 433.33% higher, now standing at 17.6.
- Over the past 195 months, CYRX's price/sales ratio has gone down 552.8.
- Over the past 195 months, CYRX's price/sales ratio has gone down 552.8.
Below are key valuation metrics over time for CYRX.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| CYRX | 2021-09-03 | 17.6 | 4.6 | -38.0 | -117.8 |
| CYRX | 2021-09-02 | 18.1 | 4.7 | -39.1 | -121.0 |
| CYRX | 2021-09-01 | 17.9 | 4.7 | -38.5 | -119.3 |
| CYRX | 2021-08-31 | 17.3 | 4.5 | -37.3 | -115.7 |
| CYRX | 2021-08-30 | 17.2 | 4.5 | -37.0 | -114.8 |
| CYRX | 2021-08-27 | 16.5 | 4.3 | -35.6 | -110.4 |
CYRX Growth Metrics
- Its 3 year cash and equivalents growth rate is now at 949.53%.
- Its 3 year net income to common stockholders growth rate is now at 38.5%.
- The 2 year net cashflow from operations growth rate now stands at 98.04%.
The table below shows CYRX's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2021-06-30 | 169.0079 | -17.92039 | -78.39536 |
| 2021-03-31 | 122.2059 | -21.91636 | -76.80911 |
| 2020-12-31 | 78.696 | -14.866 | -75.029 |
| 2020-09-30 | 39.57723 | -4.411822 | -22.111 |
| 2020-06-30 | 37.98848 | -0.381982 | -23.16173 |
| 2020-03-31 | 37.06306 | -0.074897 | -19.88747 |
CYRX's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CYRX has a Quality Grade of D, ranking ahead of 10.52% of graded US stocks.
- CYRX's asset turnover comes in at 0.276 -- ranking 163rd of 681 Pharmaceutical Products stocks.
- BDSI, INSM, and CEMI are the stocks whose asset turnover ratios are most correlated with CYRX.
The table below shows CYRX's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.276 | 0.449 | -0.073 |
| 2021-03-31 | 0.260 | 0.455 | -0.091 |
| 2020-12-31 | 0.263 | 0.462 | -0.150 |
| 2020-09-30 | 0.203 | 0.540 | -0.129 |
| 2020-06-30 | 0.229 | 0.525 | -0.165 |
| 2020-03-31 | 0.272 | 0.517 | -0.268 |
CYRX Price Target
For more insight on analysts targets of CYRX, see our CYRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $78.50 | Average Broker Recommendation | 1.25 (Strong Buy) |
CYRX Stock Price Chart Interactive Chart >
CYRX Price/Volume Stats
| Current price | $70.26 | 52-week high | $84.97 |
| Prev. close | $67.49 | 52-week low | $39.10 |
| Day low | $67.27 | Volume | 272,700 |
| Day high | $70.42 | Avg. volume | 413,384 |
| 50-day MA | $63.74 | Dividend yield | N/A |
| 200-day MA | $59.89 | Market Cap | 3.23B |
CryoPort, Inc. (CYRX) Company Bio
CryoPort, Inc. provides cryogenic logistics solutions to the life sciences industry in the United States, Europe, Asia, and internationally. The company offers Cryoportal, a cloud-based logistics management software that automates the entry of orders, prepares customs documentation, and facilitates status and location monitoring of shipped orders while in transit; and CryoPort Express Shippers, which are cryogenic dry vapor shippers that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures. The company was founded in 1999 and is based in Irvine, California.
Latest CYRX News From Around the Web
Below are the latest news stories about Cryoport Inc that investors may wish to consider to help them evaluate CYRX as an investment opportunity.
Notable Cryoport Insider Trades $2.00 Million In Company StockRichard J Berman, Director at Cryoport (NASDAQ:CYRX), made a large buy and sell of company shares on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Richard J Berman purchased 25,000 Cryoport shares at prices ranging from $14.35 to $18.02 per share for a total of $398,628 on September 15. They then sold their shares on the same day in the open market. They sold at prices ranging from $62.72 to $64.55 to rais |
Robinhood Markets, Mednax, California Resources, and Other Stocks See Action From Activist InvestorsActivists report to the SEC on Robinhood Markets, Oscar Health, CryoPort, Dynavax Technologies, California Resources, and Mednax |
5 Stocks Insiders Are SellingWhen insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision. Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform. Dropbox The Trade: Dropbox, In |
Cryoport and Mitsubishi Logistics Corporation Partner to Bring Temperature-Controlled Supply Chain Solutions to Asia-PacificCryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical research, pharmaceutical and cell and gene therapy markets, and Mitsubishi Logistics Corporation ("MLC"), Japan's leading pharma logistics company, today announced a multi-year strategic business alliance to create an integrated regenerative medicine supply chain partnership in Japan. |
Needham Stick to Their Buy Rating for CryoPort Inc By Investing.comNeedham Stick to Their Buy Rating for CryoPort Inc |
CYRX Price Returns
| 1-mo | 4.76% |
| 3-mo | 28.05% |
| 6-mo | 41.62% |
| 1-year | 50.74% |
| 3-year | 519.58% |
| 5-year | 3,637.23% |
| YTD | 60.12% |
| 2020 | 166.59% |
| 2019 | 49.23% |
| 2018 | 28.41% |
| 2017 | 165.12% |
| 2016 | 60.40% |
Continue Researching CYRX
Want to do more research on Cryoport Inc's stock and its price? Try the links below:Cryoport Inc (CYRX) Stock Price | Nasdaq
Cryoport Inc (CYRX) Stock Quote, History and News - Yahoo Finance
Cryoport Inc (CYRX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...